$INNV
InnovAge Holding Corp. Stock $innv

$innv Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-K Financial Statement

#000155837021012679 Filed on September 23, 2021

Income Statement

Concept	2021 Q2	2021 Q1	2021
Revenue	$171.6M	$156.3M	$637.8M
YoY Change	12.54%	7.97%	12.45%
Cost Of Revenue	$123.6M	$115.0M	$463.7M
YoY Change	15.5%	4.26%	8.88%
Gross Profit	$48.03M	$41.40M	$174.1M
YoY Change	5.57%	20.0%	23.2%
Gross Profit Margin	27.99%	26.49%	27.29%
Selling, General & Admin	$34.33M	$24.19M	$154.6M
YoY Change	65.86%	29.65%	99.49%
% of Gross Profit	71.48%	58.42%	88.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.034M	$3.311M	$12.29M
YoY Change	-47.23%	19.57%	8.88%
% of Gross Profit	6.32%	8.0%	7.06%
Operating Expenses	$37.37M	$24.19M	$154.6M
YoY Change	50.67%	29.65%	99.49%
Operating Profit	$10.67M	-$5.366M	-$12.34M
YoY Change	-48.46%	-141.36%	-124.22%
Interest Expense	$274.0K	$4.876M	$16.79M
YoY Change	-107.21%	106.52%	14.83%
% of Operating Profit	2.57%
Other Income/Expense, Net	-$15.00K	-$9.760M	-$22.63M
YoY Change	-115.0%	361.03%	47.92%
Pretax Income	$10.93M	-$15.10M	-$34.97M
YoY Change	-35.34%	-238.53%	-198.23%
Income Tax	$4.612M	-$4.300M	$9.771M
% Of Pretax Income	42.21%
Net Earnings	$6.474M	-$10.51M	-$43.99M
YoY Change	-46.5%	-229.15%	-267.39%
Net Earnings / Revenue	3.77%	-6.72%	-6.9%
Basic Earnings Per Share		-$0.09	-$0.36
Diluted Earnings Per Share	$47.74K	-$0.09	-$0.36
COMMON SHARES
Basic Shares Outstanding	135.5M	121.3M	123.6M
Diluted Shares Outstanding		121.3M	123.6M

Balance Sheet

Concept	2021 Q2	2021 Q1	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$201.5M	$201.5M	$201.5M
YoY Change			78.45%
Cash & Equivalents	$201.5M	$201.5M	$201.5M
Short-Term Investments
Other Short-Term Assets	$11.48M	$5.800M	$11.48M
YoY Change			91.38%
Inventory
Prepaid Expenses	$9.249M
Receivables	$32.58M	$44.36M	$32.58M
Other Receivables	$5.401M	$100.0K	$5.401M
Total Short-Term Assets	$250.9M	$251.9M	$250.9M
YoY Change	50.32%		50.35%
LONG-TERM ASSETS
Property, Plant & Equipment	$142.7M	$141.5M	$142.7M
YoY Change	39.24%		39.23%
Goodwill	$124.2M	$124.2M
YoY Change	6.94%
Intangibles	$6.518M
YoY Change	25.9%
Long-Term Investments	$848.0K	$3.500M	$3.493M
YoY Change			-78.03%
Other Assets	$3.877M	$3.600M	$3.877M
YoY Change			29.23%
Total Long-Term Assets	$280.8M	$279.5M	$280.8M
YoY Change	15.71%		15.71%
TOTAL ASSETS
Total Short-Term Assets	$250.9M	$251.9M	$250.9M
Total Long-Term Assets	$280.8M	$279.5M	$280.8M
Total Assets	$531.8M	$531.4M	$531.8M
YoY Change	29.81%		29.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$32.36M	$33.20M	$32.36M
YoY Change			11.98%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.790M	$2.852M	$5.869M
YoY Change	95.56%		72.62%
Total Short-Term Liabilities	$78.57M	$93.99M	$78.57M
YoY Change	2.52%		2.57%
LONG-TERM LIABILITIES
Long-Term Debt	$71.57M	$72.42M	$76.76M
YoY Change	-65.99%		-64.21%
Other Long-Term Liabilities	$2.758M	$2.390M	$2.758M
YoY Change	90.73%		97.0%
Total Long-Term Liabilities	$74.33M	$74.81M	$79.52M
YoY Change	-64.92%		-63.17%
TOTAL LIABILITIES
Total Short-Term Liabilities	$78.57M	$93.99M	$78.57M
Total Long-Term Liabilities	$74.33M	$74.81M	$79.52M
Total Liabilities	$173.8M	$180.3M	$196.6M
YoY Change	-42.43%		-36.29%
SHAREHOLDERS EQUITY
Retained Earnings	$10.66M	$4.820M
YoY Change	-83.53%
Common Stock	$136.0K	$136.0K
YoY Change	2.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	$0.00	$0.00
Shareholders Equity	$334.6M	$328.1M	$335.1M
YoY Change
Total Liabilities & Shareholders Equity	$531.8M	$531.4M	$531.8M
YoY Change	29.81%		29.82%

Cashflow Statement

Concept	2021 Q2	2021 Q1	2021
OPERATING ACTIVITIES
Net Income	$6.474M	-$10.51M	-$43.99M
YoY Change	-46.5%	-229.15%	-267.39%
Depreciation, Depletion And Amortization	$3.034M	$3.311M	$12.29M
YoY Change	-47.23%	19.57%	8.88%
Cash From Operating Activities	$9.482M	-$16.29M	-$7.548M
YoY Change	-68.8%		-117.22%
INVESTING ACTIVITIES
Capital Expenditures	-$3.461M	-$2.620M	$17.54M
YoY Change	-24.6%		48.1%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change	-100.0%		-100.0%
Cash From Investing Activities	-$3.461M	-$2.620M	-$19.54M
YoY Change	-39.7%		67.15%
FINANCING ACTIVITIES
Cash Dividend Paid			$9.500M
YoY Change
Common Stock Issuance & Retirement, Net		$370.5M	$77.60M
YoY Change
Debt Paid & Issued, Net			$512.7M
YoY Change			26407.76%
Cash From Financing Activities	-6.086M	143.7M	116.2M
YoY Change	-126.55%		447.4%
NET CHANGE
Cash From Operating Activities	9.482M	-16.29M	-7.548M
Cash From Investing Activities	-3.461M	-2.620M	-19.54M
Cash From Financing Activities	-6.086M	143.7M	116.2M
Net Change In Cash	-65.00K	124.8M	89.14M
YoY Change	-100.14%		67.02%
FREE CASH FLOW
Cash From Operating Activities	$9.482M	-$16.29M	-$7.548M
Capital Expenditures	-$3.461M	-$2.620M	$17.54M
Free Cash Flow	$12.94M	-$13.67M	-$25.09M
YoY Change	-63.0%		-178.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001834376
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-06-30
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4350000
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6384000
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	32582000
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	46312000
CY2020Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4311000
CY2021Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	5401000
CY2020Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1743000
CY2021Q2	us-gaap	Assets Current AssetsCurrent	250932000
CY2020Q2	us-gaap	Assets Current AssetsCurrent	166931000
CY2021Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9249000
CY2021	dei	Entity File Number EntityFileNumber	001-40159
CY2021	dei	Entity Registrant Name EntityRegistrantName	InnovAge Holding Corp
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-0710819
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	8950
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	E. Lowry Boulevard
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Denver
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80230
CY2021	dei	City Area Code CityAreaCode	844
CY2021	dei	Local Phone Number LocalPhoneNumber	803-8745
CY2021	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2021	dei	Trading Symbol TradingSymbol	INNV
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	0
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	135516513
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	201466000
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	112904000
CY2021Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	2234000
CY2020Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	1661000
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	142715000
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	102494000
CY2021Q2	us-gaap	Long Term Investments LongTermInvestments	2645000
CY2020Q2	us-gaap	Long Term Investments LongTermInvestments	2645000
CY2021Q2	innv	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	3877000
CY2020Q2	innv	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	3003000
CY2021Q2	innv	Equity Method Investment EquityMethodInvestment	848000
CY2020Q2	innv	Equity Method Investment EquityMethodInvestment	13245000
CY2021Q2	us-gaap	Goodwill Goodwill	124217000
CY2020Q2	us-gaap	Goodwill Goodwill	116139000
CY2021Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	6518000
CY2020Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	5177000
CY2021Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	280820000
CY2020Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	242703000
CY2021Q2	us-gaap	Assets Assets	531752000
CY2020Q2	us-gaap	Assets Assets	409634000
CY2021Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	32361000
CY2020Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	28875000
CY2021Q2	innv	Reported And Estimated Claims Current ReportedAndEstimatedClaimsCurrent	33234000
CY2020Q2	innv	Reported And Estimated Claims Current ReportedAndEstimatedClaimsCurrent	30291000
CY2021Q2	innv	Due To State And Federal Health Programs DueToStateAndFederalHealthPrograms	7101000
CY2020Q2	innv	Due To State And Federal Health Programs DueToStateAndFederalHealthPrograms	12244000
CY2021Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	3790000
CY2020Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	1938000
CY2021Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2079000
CY2020Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1496000
CY2020Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1789000
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	78565000
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	76633000
CY2021Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	15700000
CY2020Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	9282000
CY2021Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	5190000
CY2020Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4091000
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2758000
CY2020Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1446000
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	71574000
CY2020Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	210432000
CY2021Q2	us-gaap	Liabilities Liabilities	173787000
CY2020Q2	us-gaap	Liabilities Liabilities	301884000
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	135516513
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	132718461
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	136000
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	133000
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	323760000
CY2020Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	36338000
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11250000
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	64737000
CY2021Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	0
CY2020Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	102030
CY2021	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	0.0
CY2020	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	1.89
CY2020Q2	us-gaap	Treasury Stock Value TreasuryStockValue	193000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	132616431
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	123618702
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	335146000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	101015000
CY2021Q2	us-gaap	Minority Interest MinorityInterest	22819000
CY2020Q2	us-gaap	Minority Interest MinorityInterest	6735000
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	357965000
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	107750000
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	531752000
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	409634000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	637800000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	567192000
CY2021	innv	External Provider Costs ExternalProviderCosts	309317000
CY2020	innv	External Provider Costs ExternalProviderCosts	272832000
CY2021	us-gaap	Direct Operating Costs DirectOperatingCosts	154403000
CY2020	us-gaap	Direct Operating Costs DirectOperatingCosts	153056000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	22236000
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	19001000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	132333000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	58481000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12294000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11291000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1343000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-678000
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-18211000
CY2020	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-920000
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	650137000
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	516259000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-12337000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	50933000
CY2021	us-gaap	Interest Expense InterestExpense	16787000
CY2020	us-gaap	Interest Expense InterestExpense	14619000
CY2021	innv	Gain Loss On Extinguishment Of Debt Before Write Off Of Debt Issuance Cost GainLossOnExtinguishmentOfDebtBeforeWriteOffOfDebtIssuanceCost	-14479000
CY2021	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	10871000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2237000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-681000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-22632000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15300000
CY2021	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-34969000
CY2020	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	35633000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9771000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9868000
CY2021	us-gaap	Profit Loss ProfitLoss	-44740000
CY2020	us-gaap	Profit Loss ProfitLoss	25765000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-754000
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-513000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-43986000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	26278000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	123618702
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	135233630
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2021	innv	Gain Loss In Equity Of Nonconsolidated Entities GainLossInEquityOfNonconsolidatedEntities	-1343000
CY2020	innv	Gain Loss In Equity Of Nonconsolidated Entities GainLossInEquityOfNonconsolidatedEntities	-678000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2264000
CY2020	innv	Fair Value Of Contingent Consideration FairValueOfContingentConsideration	920000
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	81442000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	543000
CY2020	us-gaap	Profit Loss ProfitLoss	25765000
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	107750000
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	77603000
CY2021	innv	Stock Option Cancellation Value StockOptionCancellationValue	9501000
CY2021	innv	Adjustments To Additional Paid In Capital Time Based Awards Option Cancelation AdjustmentsToAdditionalPaidInCapitalTimeBasedAwardsOptionCancelation	29175000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1664000
CY2021	innv	Adjustments To Additional Paid In Capital Reclassification Of Warrant Liability AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantLiability	2264000
CY2021	innv	Adjustments To Additional Paid In Capital Owners Contribution AdjustmentsToAdditionalPaidInCapitalOwnersContribution	20000000
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	28445000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	370468000
CY2021	innv	Noncontrolling Interest Increase From Consolidation Of Equity Method Investment NoncontrollingInterestIncreaseFromConsolidationOfEquityMethodInvestment	16838000
CY2021	us-gaap	Profit Loss ProfitLoss	-44740000
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	357965000
CY2021	us-gaap	Profit Loss ProfitLoss	-44740000
CY2020	us-gaap	Profit Loss ProfitLoss	25765000
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-18000
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1039000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8637000
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6204000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12294000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11291000
CY2021	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	10871000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-14479000
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1056000
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	550000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1664000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	543000
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	6418000
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	3173000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5879000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1202000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4987000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1062000
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	3658000
CY2020	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-1952000
CY2021	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	874000
CY2020	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-1063000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6137000
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1013000
CY2021	innv	Increase Decrease In Reported And Estimated Claims IncreaseDecreaseInReportedAndEstimatedClaims	2613000
CY2020	innv	Increase Decrease In Reported And Estimated Claims IncreaseDecreaseInReportedAndEstimatedClaims	2045000
CY2021	innv	Increase Decrease In Due To State And Federal Health Programs IncreaseDecreaseInDueToStateAndFederalHealthPrograms	-5220000
CY2020	innv	Increase Decrease In Due To State And Federal Health Programs IncreaseDecreaseInDueToStateAndFederalHealthPrograms	-8120000
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7548000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	43828000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17541000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11844000
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	169000
CY2020	innv	Proceeds From Net Working Capital Settlements ProceedsFromNetWorkingCapitalSettlements	1129000
CY2020	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	1145000
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2000000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19541000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11691000
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	9500000
CY2021	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	20000000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1788000
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1834000
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	375000000
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	25000000
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	512660000
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1934000
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	14896000
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	370468000
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	77603000
CY2021	innv	Payments Under Acquisition Agreement PaymentsUnderAcquisitionAgreement	3622000
CY2021	innv	Payments Related To Option Cancellation PaymentsRelatedToOptionCancellation	29175000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	116224000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21232000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	89135000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	53369000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	114565000
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	61196000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	203700000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	114565000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	18030000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	11551000
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	7048000
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	4745000
CY2021	innv	Property And Equipment Included In Accounts Payable PropertyAndEquipmentIncludedInAccountsPayable	1327000
CY2020	innv	Property And Equipment Included In Accounts Payable PropertyAndEquipmentIncludedInAccountsPayable	1348000
CY2021	innv	Property And Equipment Purchased Under Capital Leases PropertyAndEquipmentPurchasedUnderCapitalLeases	3493000
CY2020	innv	Property And Equipment Purchased Under Capital Leases PropertyAndEquipmentPurchasedUnderCapitalLeases	1399000
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2329234
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	370500000
CY2021Q1	innv	Underwriting Discounts And Commission UnderwritingDiscountsAndCommission	23900000
CY2021Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	4500000
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 10pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:13.5pt;margin:0pt 0pt 10pt 0pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used in accounting for, among other things, the allowance for uncollectible accounts; useful lives of property and equipment and the valuation of goodwill and intangible assets; risk-score adjustments to participant revenues; reported and estimated claims; accruals; the determination of assumptions for stock-based compensation costs; deferred taxes, including the determination of a need for a valuation allowance; valuation of the contingent consideration; legal contingencies, including medical malpractice claims; the determination of fair value of net assets acquired in a business combination; and other fair value measurements. Actual results may differ from previously estimated amounts.</p>
CY2020Q2	us-gaap	Long Term Investments LongTermInvestments	2600000
CY2021Q2	us-gaap	Long Term Investments LongTermInvestments	2600000
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4400000
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6400000
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	187491000
CY2020Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	135364000
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	44776000
CY2020Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	32870000
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	142715000
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	102494000
CY2021	us-gaap	Depreciation Depreciation	11600000
CY2020	us-gaap	Depreciation Depreciation	10600000
CY2020	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	1100000
CY2021Q2	us-gaap	Accumulated Capitalized Interest Costs AccumulatedCapitalizedInterestCosts	1000000.0
CY2020Q2	us-gaap	Accumulated Capitalized Interest Costs AccumulatedCapitalizedInterestCosts	100000
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2020	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0
CY2021	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0
CY2021	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2020	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2021	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2021Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0
CY2021	innv	Percentage Of Pooled Capitated Payment Received PercentageOfPooledCapitatedPaymentReceived	1
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9000000.0
CY2020Q4	innv	Number Of Equity Method Investments NumberOfEquityMethodInvestments	2
CY2020	us-gaap	Advertising Expense AdvertisingExpense	8000000.0
CY2021	us-gaap	Advertising Expense AdvertisingExpense	6500000
CY2019Q1	us-gaap	Land Land	4200000
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2300000
CY2021Q2	innv	Reimbursement Amount Allocated Covid19 ReimbursementAmountAllocatedCovid19	1000000.0
CY2020	innv	Reimbursement Amount Recognized Covid19 ReimbursementAmountRecognizedCovid19	700000
CY2021	innv	Reimbursement Amount Recognized Covid19 ReimbursementAmountRecognizedCovid19	300000
CY2020Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	22600000
CY2020Q3	us-gaap	Dividends Dividends	9500000
CY2020	innv	Number Of Acquisitions NumberOfAcquisitions	0
CY2021	innv	Number Of Acquisitions NumberOfAcquisitions	0
CY2021	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.279
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.28
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	innv	Gain Loss On Consolidation GainLossOnConsolidation	10900000
CY2020	innv	Equity Securities Increase Decrease From Observable Price Changes EquitySecuritiesIncreaseDecreaseFromObservablePriceChanges	0
CY2021	innv	Equity Securities Increase Decrease From Observable Price Changes EquitySecuritiesIncreaseDecreaseFromObservablePriceChanges	0
CY2020Q2	us-gaap	Goodwill Goodwill	116139000
CY2019Q2	us-gaap	Goodwill Goodwill	117268000
CY2020	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	-1129000
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	8078000
CY2021Q2	us-gaap	Goodwill Goodwill	124217000
CY2020Q2	us-gaap	Goodwill Goodwill	116139000
CY2021Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	77367000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6600000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6600000
CY2021Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2000000
CY2021Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	8600000
CY2020Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	6600000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2082000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1423000
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6518000
CY2020Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5177000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	700000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	600000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	660000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	660000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	660000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	660000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	660000
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2021	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4500000
CY2020	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4800000
CY2021	innv	Effective Income Tax Rate Reconciliation Transaction Costs EffectiveIncomeTaxRateReconciliationTransactionCosts	2770000
CY2021Q2	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	2524000
CY2021Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	3550000
CY2021Q2	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	2468000
CY2021Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	4289000
CY2021Q2	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	1941000
CY2021Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	3926000
CY2021Q2	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	1169000
CY2021Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	3450000
CY2021Q2	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	134000
CY2021Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	3371000
CY2021Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	13909000
CY2021Q2	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	8236000
CY2021Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	32495000
CY2021Q2	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	967000
CY2021Q2	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	7269000
CY2021Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	2079000
CY2021Q2	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	5190000
CY2018Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	20000000.0
CY2021Q1	innv	Business Combination Contingent Consideration Paid BusinessCombinationContingentConsiderationPaid	20000000.0
CY2021Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0
CY2021Q1	innv	Business Combination Contingent Consideration Paid BusinessCombinationContingentConsiderationPaid	20000000.0
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-7343000
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	7483000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	12526000
CY2020Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	215026000
CY2021Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-2003000
CY2020Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-2656000
CY2021Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	3790000
CY2020Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	1938000
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	71574000
CY2020Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	210432000
CY2021Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2000000.0
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1100000
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	600000
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3790000
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3793000
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	3796000
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	3799000
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	60052000
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	2137000
CY2021Q2	us-gaap	Long Term Debt LongTermDebt	77367000
CY2020Q2	innv	Deferred Tax Assets Reported And Estimated Claims DeferredTaxAssetsReportedAndEstimatedClaims	889000
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	428000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	47051000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	543000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.349
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.393
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0051
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.018
CY2021	innv	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue	0.48
CY2021	innv	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Fair Value Of Derivative ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValueOfDerivative	4.82
CY2020Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	16095819
CY2020Q3	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	4.82
CY2020Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	77600000
CY2021Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0
CY2021	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1887000
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	856000
CY2021Q2	innv	Deferred Tax Assets Accrued Bonuses DeferredTaxAssetsAccruedBonuses	65000
CY2020Q2	innv	Deferred Tax Assets Accrued Bonuses DeferredTaxAssetsAccruedBonuses	38000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1500000
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-128000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	306000
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	268000
CY2021	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-227000
CY2020	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	347000
CY2021	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-66000
CY2020	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-108000
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	173000
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1790000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9771000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9868000
CY2021	innv	Number Of Officers Highest Compensation Paid NumberOfOfficersHighestCompensationPaid	5
CY2021	innv	Effective Income Tax Rate Reconciliation Nondeductible Expense Compensation Paid EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationPaid	1000000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2710000
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	5382000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	642000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1313000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3352000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	6695000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	5342000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	2349000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1077000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	824000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6419000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3173000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9771000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9868000
CY2021Q2	innv	Deferred Tax Assets Amortization DeferredTaxAssetsAmortization	2241000
CY2020Q2	innv	Deferred Tax Assets Amortization DeferredTaxAssetsAmortization	2033000
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	1887000
CY2020Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	387000
CY2021Q2	innv	Deferred Tax Assets Transaction Costs DeferredTaxAssetsTransactionCosts	1092000
CY2020Q2	innv	Deferred Tax Assets Transaction Costs DeferredTaxAssetsTransactionCosts	1204000
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1112000
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1644000
CY2021Q2	innv	Deferred Tax Assets Accrued Vacation DeferredTaxAssetsAccruedVacation	979000
CY2020Q2	innv	Deferred Tax Assets Accrued Vacation DeferredTaxAssetsAccruedVacation	984000
CY2021Q2	innv	Deferred Tax Assets Reported And Estimated Claims DeferredTaxAssetsReportedAndEstimatedClaims	941000
CY2021Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	8745000
CY2020Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	8035000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	135233630
CY2020Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	387000
CY2021Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6858000
CY2020Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	7648000
CY2021Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	9934000
CY2020Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	8057000
CY2021Q2	innv	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	7394000
CY2020Q2	innv	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	8053000
CY2021Q2	innv	Deferred Tax Liabilities Equity Method Investments DeferredTaxLiabilitiesEquityMethodInvestments	3222000
CY2020Q2	innv	Deferred Tax Liabilities Equity Method Investments DeferredTaxLiabilitiesEquityMethodInvestments	6000
CY2021Q2	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	2008000
CY2020Q2	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	814000
CY2021Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	22558000
CY2020Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	16930000
CY2021Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	15700000
CY2020Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	9282000
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1900000
CY2020Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	400000
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	35000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-43986000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	26278000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	123618702
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	132616431
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2617199
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	123618702
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19

Files In Submission

Name	View Source	Status
0001558370-21-012679-index-headers.html	Edgar Link	pending
0001558370-21-012679-index.html	Edgar Link	pending
0001558370-21-012679.txt	Edgar Link	pending
0001558370-21-012679-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tmb-20210630.xsd	Edgar Link	pending
tmb-20210630x10k.htm	Edgar Link	pending
tmb-20210630x10k004.jpg	Edgar Link	pending
tmb-20210630x10k007.jpg	Edgar Link	pending
tmb-20210630x10k_htm.xml	Edgar Link	completed
tmb-20210630xex21.htm	Edgar Link	pending
tmb-20210630xex23.htm	Edgar Link	pending
tmb-20210630xex31d1.htm	Edgar Link	pending
tmb-20210630xex31d2.htm	Edgar Link	pending
tmb-20210630xex32d1.htm	Edgar Link	pending
tmb-20210630xex32d2.htm	Edgar Link	pending
tmb-20210630xex4d1.htm	Edgar Link	pending
tmb-20210630xex4d3.htm	Edgar Link	pending
tmb-20210630_cal.xml	Edgar Link	unprocessable
tmb-20210630_def.xml	Edgar Link	unprocessable
tmb-20210630_lab.xml	Edgar Link	unprocessable
tmb-20210630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INNV
InnovAge Holding Corp. Stock $innv

2021 Q2 Form 10-K Financial Statement

#000155837021012679 Filed on September 23, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INNV InnovAge Holding Corp. Stock $innv

2021 Q2 Form 10-K Financial Statement

#000155837021012679 Filed on September 23, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INNV
InnovAge Holding Corp. Stock $innv